UNIVERSITY OF EAST ANGLIA Patent applications |
Patent application number | Title | Published |
20140243213 | Analysing Sequencing Bias - The present invention relates to methods for determining the sequence bias of a sequencing technique. Furthermore, the invention relates to methods to reduce or enhance sequence bias during sequencing of nucleic acids via techniques involving adaptor ligations. Specifically the method relates to use of a degenerate RNA sequence to analyse sequence bias when generating small RNA libraries, and to the use of modified adaptors for cloning of small RNAs with degenerate or specific sequences to reduce or enhance sequencing bias, as well as various nucleic acid molecules relating thereto or derived therefrom. | 08-28-2014 |
20140197335 | METHODS, SYSTEMS AND DEVICES FOR DETECTING INSECTS AND OTHER PESTS - We describe a method for detection of the presence of an invertebrate or an invertebrate component in a sample of substantially non invertebrate material, comprising impinging said sample with a source of electromagnetic radiation at a wavelength of at least 600 nm and detecting Raman scattering/fluorescence of said invertebrate or a component of said invertebrate at a wavenumber where the non-invertebrate components of said sample either do not fluoresce or fluoresce with sufficiently low intensity wherein the non invertebrate material is edible and/or living. | 07-17-2014 |
20130333074 | ENHANCER OF CELL DIVISION - The present invention relates to a polypeptide (BIG1) and variants thereof capable of enhancing the rate of cell-division of a microorganism or plant cell, as well as nucleic acid molecules encoding said polypeptides, vectors comprising said nucleic acid molecules and host cells transformed or transfected with said vectors and expressing said polypeptides. The BIG1 polypeptide which has been identified in the marine centric diatom | 12-12-2013 |
20110236395 | TREATMENT OF FIBROTIC EYE DISORDERS USING AN MMP2 INHIBITOR - Inhibitors of matrix metalloproteinase 2 are used to treat or prevent a fibrotic disorder of the posterior capsule of the eye, for example posterior capsule opacification (PCO), or of a tissue or structure of the eye other than the lens or capsular bag. | 09-29-2011 |
20110223177 | TREATMENT OF FIBROTIC EYE DISORDERS - Inhibitors of myosin activity are used to treat or prevent a fibrotic disorder of the eye, for example posterior capsule opacification (PCO). | 09-15-2011 |